World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
72
Citations
18410
World Ranking
19843
National Ranking
9885

Overview

Gregory L. Kearns is affiliated with the University of Arkansas for Medical Sciences in the United States. Their research primarily centers on medicine, with a strong focus on pediatrics, perinatology, and child health. Additional notable subfields in their work include pharmacology, epidemiology, infectious diseases, and gastroenterology.

The scientist has contributed to several areas related to pharmaceutical studies and practices, antibiotics pharmacokinetics and efficacy, pneumonia and respiratory infections, gastrointestinal motility and disorders, antimicrobial resistance in Staphylococcus, neonatal health and biochemistry, as well as biochemical analysis and sensing techniques.

Gregory L. Kearns has authored and co-authored numerous papers in well-established journals. Some recent publications include:

  • Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling, 2021, Clinical Pharmacokinetics
  • Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants, 2021, Clinical Pharmacokinetics
  • Randomised trial: Peppermint oil (menthol) pharmacokinetics in children and effects on gut motility in children with functional abdominal pain, 2021, British Journal of Clinical Pharmacology
  • Peppermint oil effects on the gut microbiome in children with functional abdominal pain, 2022, Clinical and Translational Science
  • Pharmacokinetics of Ceftazidime in Children and Adolescents with Obesity, 2021, Pediatric Drugs

Kearns frequently publishes in journals such as Clinical Pharmacokinetics, Pediatric Drugs, British Journal of Clinical Pharmacology, and Clinical and Translational Science, with Clinical Pharmacokinetics and UNC Libraries featuring the highest number of their publications.

Their collaborative work involves repeated partnerships with several co-authors, including:

  • Ian M. Paul
  • Daniel K. Benjamin
  • Kelly C. Wade
  • Chi D. Hornik
  • Christoph P. Hornik

Throughout their career, Kearns has developed expertise in pharmacokinetic modeling, especially in pediatric populations with special considerations such as obesity and prematurity. Their research covers both clinical trials and modeling studies, addressing medication dosing, efficacy, and pharmacodynamics in children.

Best Publications

  • Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children

    Gregory L. Kearns;Susan M. Abdel-Rahman;Sarah W. Alander;Douglas L. Blowey

  • Cytochrome P450 3A: ontogeny and drug disposition.

    S N de Wildt;G L Kearns;J S Leeder;J N van den Anker

  • Glucuronidation in humans. Pharmacogenetic and developmental aspects

    S N de Wildt;G L Kearns;J S Leeder;J N van den Anker;J N van den Anker

  • Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: a phase I study in children.

    Catherine Pihoker;Gregory L. Kearns;Gregory L. Kearns;Daniel French;Cyril Y. Bowers

  • Developmental Changes in Pharmacokinetics and Pharmacodynamics.

    John van den Anker;John van den Anker;Michael D. Reed;Karel Allegaert;Karel Allegaert;Gregory L. Kearns

  • Clinical pharmacokinetics in infants and children. A reappraisal.

    Gregory L. Kearns;Michael D. Reed

  • PHARMACOGENETICS IN PEDIATRICS: Implications for Practice

    J. Steven Leeder;Gregory L. Kearns

  • Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data.

    Andrea Gaedigk;R. Gotschall;Nataŝa Forbes;Stephen Simon

  • The selection and use of essential medicines.

    P Kazembe;JM Al-Fannah;K Hoppu;E Zisovska

  • The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants.

    Gloria P Heresi;Dale R Gerstmann;Michael D Reed;John N van den Anker;John N van den Anker

  • Ontogeny of drug metabolizing enzymes in the neonate.

    Michael J. Blake;Lisa Castro;J. Steven Leeder;Gregory L. Kearns

  • Proton pump inhibitors in pediatrics : mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics.

    Robert M. Ward;Gregory L. Kearns

  • Combined phenotypic assessment of cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A, N‐acetyltransferase‐2, and xanthine oxidase activities with the “Cooperstown 5+1 cocktail”

    Siwaporn Chainuvati;Anne N. Nafziger;J. Steven Leeder;Andrea Gaedigk

  • Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".

    Daniel S. Streetman;Jeffrey F. Bleakley;Jooran S. Kim;Anne N. Nafziger

  • Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates

    P Brian Smith;Thomas J. Walsh;William Hope;Antonio Arrieta

  • Ontogeny of Dextromethorphan O‐ and N‐demethylation in the First Year of Life

    M. J. Blake;A. Gaedigk;R. E. Pearce;L. R. Bomgaars

  • Single-dose pharmacokinetics of ibuprofen and acetaminophen in febrile children.

    R. Don Brown;John T. Wilson;Gregory L. Kearns;Gregory L. Kearns;Valarie F. Eichler

  • Cocaine: clinical pharmacology and toxicology.

    Henry C. Farrar;Gregory L. Kearns;Gregory L. Kearns

  • Dosing implications of altered gentamicin disposition in patients with cystic fibrosis.

    Gregory L. Kearns;D Pharm;Bettina C. Hilman;John T. Wilson

  • Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus

    Bart Van Overmeire;Daan Touw;Paul J. C. Schepens;Gregory L. Kearns

Frequent Co-Authors

J. Steven Leeder
J. Steven Leeder Children's Mercy Hospital
Andrea Gaedigk
Andrea Gaedigk University of Missouri–Kansas City
Daniel K. Benjamin
Daniel K. Benjamin Duke University
Angela D. M. Kashuba
Angela D. M. Kashuba University of North Carolina at Chapel Hill
Pippa Simpson
Pippa Simpson Medical College of Wisconsin
John S. Bradley
John S. Bradley University of California, San Diego
Jack A. Hinson
Jack A. Hinson University of Arkansas for Medical Sciences
Rachel F. Tyndale
Rachel F. Tyndale University of Toronto
Thomas J. Walsh
Thomas J. Walsh Weill Cornell Medicine
Ram Yogev
Ram Yogev Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to various related degrees and career paths that can complement or offer alternatives to traditional medical studies. For those seeking quick career entry or advancement in healthcare management, an accelerated healthcare administration degree online offers a flexible way to develop leadership skills and prepare for pivotal roles in the healthcare system.

Registered nurses aiming to expand their scope can benefit from flexible rn to np programs online, allowing career progress from nursing to advanced practice positions like nurse practitioner, often with minimal disruption to their current work schedule.

Students passionate about nutrition and wellness may consider a best online food science degree, which can lead to roles in research, public health, or the food industry. Likewise, those looking to lead in healthcare organizations can pursue online mha programs accredited by CAHME for targeted expertise in healthcare administration.

These online pathways provide flexibility and specialization—helping you shape a healthcare career that fits your personal goals and the industry's evolving needs.

Best Scientists Citing Gregory L. Kearns

Trending Scientists